Owner Amgen Inc.

Inventors Boone, Thomas Charles; Han, Hq; Min, Hosung

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010201389

Parent 2003301195

Filing date 7 April 2010

Wipo publication date 29 April 2010

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C07K 14/495 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides